MICHELLE DUPLANTIS: Open Payments
NPI 1457742199 · PRAIRIEVILLE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,711 in 89 payments from 23 companies in 2025. Trend: 2023 $1,937 · 2024 $1,251 · 2025 $1,711
Food & beverage: $1,711
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $291 |
| Amgen Inc. | 10 | $201 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $162 |
| Lilly USA, LLC | 6 | $116 |
| Axsome Therapeutics, Inc. | 4 | $108 |
| Novo Nordisk Inc | 6 | $99 |
| GlaxoSmithKline, LLC. | 5 | $97 |
| Janssen Pharmaceuticals, Inc | 5 | $93 |
| Abbott Laboratories | 4 | $88 |
| Lundbeck LLC | 4 | $87 |
Products named: CAPLYTA, VRAYLAR, REPATHA, UBRELVY, Auvelity, MOUNJARO, SPRAVATO, REXULTI.
Industry payments across LA — which companies pay providers there.
